These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 7710983)
1. Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: identification of prognostic factors. Dimopoulos MA; Weber D; Delasalle KB; Keating M; Alexanian R Ann Oncol; 1995 Jan; 6(1):49-52. PubMed ID: 7710983 [TBL] [Abstract][Full Text] [Related]
2. Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine. Dimopoulos MA; Kantarjian H; Weber D; O'Brien S; Estey E; Delasalle K; Rose E; Cabanillas F; Keating M; Alexanian R J Clin Oncol; 1994 Dec; 12(12):2694-8. PubMed ID: 7989946 [TBL] [Abstract][Full Text] [Related]
6. 2-Chlorodeoxyadenosine treatment of Waldenström's macroglobulinemia--the analysis of own experience and the review of literature. Lewandowski K; Zaucha JM; Bieniaszewska M; Hałaburda K; Hellmann A Med Sci Monit; 2000; 6(4):740-5. PubMed ID: 11208402 [TBL] [Abstract][Full Text] [Related]
7. Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenström's macroglobulinemia. Hellmann A; Lewandowski K; Zaucha JM; Bieniaszewska M; Hałaburda K; Robak T Eur J Haematol; 1999 Jul; 63(1):35-41. PubMed ID: 10414453 [TBL] [Abstract][Full Text] [Related]
8. 2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia. Weber DM; Dimopoulos MA; Delasalle K; Rankin K; Gavino M; Alexanian R Semin Oncol; 2003 Apr; 30(2):243-7. PubMed ID: 12720145 [TBL] [Abstract][Full Text] [Related]
9. Response of meningeal Waldenström's macroglobulinemia to 2-chlorodeoxyadenosine. Richards AI J Clin Oncol; 1995 Sep; 13(9):2476. PubMed ID: 7666113 [No Abstract] [Full Text] [Related]
10. Fludarabine therapy in Waldenström's macroglobulinemia patients treated previously with 2-chlorodeoxyadenosine. Lewandowski K; Halaburda K; Hellmann A Leuk Lymphoma; 2002 Feb; 43(2):361-3. PubMed ID: 11999570 [TBL] [Abstract][Full Text] [Related]
11. Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia. Swiss Group for Clinical Cancer Research (SAKK). Betticher DC; Hsu Schmitz SF; Ratschiller D; von Rohr A; Egger T; Pugin P; Stalder M; Hess U; Fey MF; Cerny T Br J Haematol; 1997 Nov; 99(2):358-63. PubMed ID: 9375754 [TBL] [Abstract][Full Text] [Related]
12. 2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine. Dimopoulos MA; Weber DM; Kantarjian H; Keating M; Alexanian R Ann Oncol; 1994 Mar; 5(3):288-9. PubMed ID: 7514439 [TBL] [Abstract][Full Text] [Related]
13. First-line treatment of Waldenström's disease with cladribine. Arbeitsgemeinschaft Medikamentöse Tumortherapie. Fridrik MA; Jäger G; Baldinger C; Krieger O; Chott A; Bettelheim P Ann Hematol; 1997 Jan; 74(1):7-10. PubMed ID: 9031608 [TBL] [Abstract][Full Text] [Related]
14. Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases: natural evolution or iatrogenic causation? Ling S; Joshua DE; Gibson J; Young G; Iland H; Watson G; Ho PJ Am J Hematol; 2006 Feb; 81(2):110-4. PubMed ID: 16432856 [TBL] [Abstract][Full Text] [Related]
16. Refractory Waldenström's macroglobulinaemia responsive to 2-chlorodeoxyadenosine and mycophenolate mofetil. Gladstone DE Leuk Res; 2008 Sep; 32(9):1487-8. PubMed ID: 18378308 [No Abstract] [Full Text] [Related]
17. Fludarabine treatment in resistant Waldenstrom's macroglobulinemia. Zinzani PL; Gherlinzoni F; Bendandi M; Zaccaria A; Aitini E; Salvucci M; Tura S Eur J Haematol; 1995 Feb; 54(2):120-3. PubMed ID: 7698295 [TBL] [Abstract][Full Text] [Related]
18. Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases. Groupe Coopératif Macroglobulinémie. Leblond V; Ben-Othman T; Deconinck E; Taksin AL; Harousseau JL; Delgado MA; Delmer A; Maloisel F; Mariette X; Morel P; Clauvel JP; Duboisset P; Entezam S; Hermine O; Merlet M; Yakoub-Agha I; Guibon O; Caspard H; Fort N J Clin Oncol; 1998 Jun; 16(6):2060-4. PubMed ID: 9626204 [TBL] [Abstract][Full Text] [Related]
19. Idelalisib in a patient with refractory Waldenström's macroglobulinemia complicated by anuric renal failure: a case report. D'Aveni-Piney M; Divoux M; Busby-Venner H; Muller M; Broséus J; Feugier P J Med Case Rep; 2018 Jun; 12(1):164. PubMed ID: 29890999 [TBL] [Abstract][Full Text] [Related]
20. Marked increase in serum IgM during treatment of Waldenstrom's macroglobulinemia with cladribine. Krishna VM; Carey RW; Bloch KJ N Engl J Med; 2003 May; 348(20):2045-6. PubMed ID: 12748329 [No Abstract] [Full Text] [Related] [Next] [New Search]